Manuela Dürr

1.1k total citations
10 papers, 776 citations indexed

About

Manuela Dürr is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Manuela Dürr has authored 10 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Manuela Dürr's work include Immune Response and Inflammation (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Antimicrobial Peptides and Activities (3 papers). Manuela Dürr is often cited by papers focused on Immune Response and Inflammation (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Antimicrobial Peptides and Activities (3 papers). Manuela Dürr collaborates with scholars based in Germany, United States and Australia. Manuela Dürr's co-authors include Andreas Peschel, Michaël Otto, Stefan Steidl, Andrew D. Cook, John A. Hamilton, Derek Lacey, Jos A. G. van Strijp, Sascha A. Kristian, Aaron Carmody and Seymour J. Klebanoff and has published in prestigious journals such as Cancer Research, Journal of Bacteriology and Infection and Immunity.

In The Last Decade

Manuela Dürr

10 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuela Dürr Germany 9 376 253 237 218 88 10 776
Ewa Bielecka Poland 14 230 0.6× 85 0.3× 72 0.3× 198 0.9× 135 1.5× 29 768
Youhui Si China 15 305 0.8× 59 0.2× 143 0.6× 226 1.0× 97 1.1× 39 734
Lynne Foster United States 14 199 0.5× 96 0.4× 246 1.0× 87 0.4× 37 0.4× 20 702
Carly Dillen United States 14 205 0.5× 69 0.3× 174 0.7× 164 0.8× 45 0.5× 28 704
Daniel T. MacLeod United States 10 435 1.2× 190 0.8× 160 0.7× 300 1.4× 35 0.4× 11 1.4k
Susan Szathmáry Hungary 15 145 0.4× 217 0.9× 70 0.3× 172 0.8× 42 0.5× 36 622
Andrés Mori United States 7 613 1.6× 90 0.4× 174 0.7× 625 2.9× 22 0.3× 7 1.3k
Kimiharu Hirose Japan 14 264 0.7× 107 0.4× 43 0.2× 129 0.6× 33 0.4× 29 597
Isabel Wong‐Baeza Mexico 18 302 0.8× 58 0.2× 122 0.5× 619 2.8× 328 3.7× 45 1.1k
Minjun Yu China 15 305 0.8× 186 0.7× 39 0.2× 205 0.9× 29 0.3× 54 749

Countries citing papers authored by Manuela Dürr

Since Specialization
Citations

This map shows the geographic impact of Manuela Dürr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuela Dürr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuela Dürr more than expected).

Fields of papers citing papers by Manuela Dürr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuela Dürr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuela Dürr. The network helps show where Manuela Dürr may publish in the future.

Co-authorship network of co-authors of Manuela Dürr

This figure shows the co-authorship network connecting the top 25 collaborators of Manuela Dürr. A scholar is included among the top collaborators of Manuela Dürr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuela Dürr. Manuela Dürr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hinner, Marlon J., Thomas J. Jaquin, Sven Berger, et al.. (2017). Abstract 3673: Preclinical toxicology and pharmacology for the 4-1BB/HER2 bispecific PRS-343: A first-in-class costimulatory T cell engager. Cancer Research. 77(13_Supplement). 3673–3673. 2 indexed citations
2.
Cook, Andrew D., Shannon Sarros, Stefan Steidl, et al.. (2012). Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain. Annals of the Rheumatic Diseases. 72(2). 265–270. 77 indexed citations
3.
Cook, Andrew D., Stefan Steidl, Manuela Dürr, et al.. (2012). Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development. Arthritis Research & Therapy. 14(5). R199–R199. 100 indexed citations
4.
Kretschmer, Dorothee, et al.. (2011). The Virulence Regulator Agr Controls the Staphylococcal Capacity to Activate Human Neutrophils via the Formyl Peptide Receptor 2. Journal of Innate Immunity. 4(2). 201–212. 35 indexed citations
5.
Steidl, Stefan, et al.. (2008). In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. Molecular Immunology. 46(1). 135–144. 75 indexed citations
6.
Dürr, Manuela, Sascha A. Kristian, Michaël Otto, et al.. (2005). Neutrophil chemotaxis by pathogen-associated molecular patterns - formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cellular Microbiology. 8(2). 207–217. 43 indexed citations
8.
Somerville, Greg A., Alan Cockayne, Manuela Dürr, et al.. (2003). Synthesis and Deformylation of Staphylococcus aureus δ-Toxin Are Linked to Tricarboxylic Acid Cycle Activity. Journal of Bacteriology. 185(22). 6686–6694. 94 indexed citations
9.
Kristian, Sascha A., Manuela Dürr, Jos A. G. van Strijp, Birgid Neumeister, & Andreas Peschel. (2002). MprF-Mediated Lysinylation of Phospholipids in Staphylococcus aureus Leads to Protection against Oxygen-Independent Neutrophil Killing. Infection and Immunity. 71(1). 546–549. 97 indexed citations
10.
Dürr, Manuela & Andreas Peschel. (2002). Chemokines Meet Defensins: the Merging Concepts of Chemoattractants and Antimicrobial Peptides in Host Defense. Infection and Immunity. 70(12). 6515–6517. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026